Skip to main content

Troxyca ER

Generic name: naltrexone hydrochloride and oxycodone hydrochloride
Drug class: Narcotic analgesic combinations
Approval date: August 19, 2016
Company: Pfizer Inc.

Medically reviewed by Drugs.com. Last updated on Aug 23, 2023.

Treatment for: Severe Pain

FDA Approves Troxyca ER

The U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride), an extended-release opioid agonist and opioid antagonist abuse-deterrent formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Troxyca ER Medication Guide

Read this Medication Guide before you start treatment and each time you get a refill. There may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.

Warnings

Do not take this medicine if you have:

Before you start treatment, tell your healthcare provider if you have a history of:

Tell your healthcare provider if you are:

When taking Troxyca ER:

While ta king Troxyca ER DO NOT:

Troxyca ER side effects

Possible side effects include:

Call your healthcare provider if you have any of these symptoms and they are severe.

Get emergency medical help if you have:

These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.